Literature DB >> 10838498

RT-PCR suggests human skeletal muscle origin of alveolar soft-part sarcoma.

H Nakano1, A Tateishi, T Imamura, H Miki, T Ohno, T Moue, M Sekiguchi, K Unno, S Abe, T Matsushita, Y Katoh, T Itoh.   

Abstract

In 1952, Christopherson et al. proposed that alveolar soft-part sarcoma (ASPS) was a distinct entity with unique clinical and pathological features. Since their report, its histogenesis has not been determined. In order to clarify the histogenesis of ASPS, a study using reverse transcription polymerase chain reaction using cDNAs from MyoD1 and myogenin, and the actin filament from human-skeletal-muscle-related mRNAs has been performed in 5 cases of ASPS. The expression of MyoD1 and myogenin was determined in 5 and 2 cases of the 5 cases, respectively. Moreover, expression of the many mRNAs from the actin filament of skeletal muscle was also found in ASPS. According to these findings, it is now postulated that ASPS is of skeletal muscle origin. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838498     DOI: 10.1159/000012119

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  3 in total

1.  High-resolution array CGH and gene expression profiling of alveolar soft part sarcoma.

Authors:  Shamini Selvarajah; Saumyadipta Pyne; Eleanor Chen; Ramakrishna Sompallae; Azra H Ligon; Gunnlaugur P Nielsen; Glenn Dranoff; Edward Stack; Massimo Loda; Richard Flavin
Journal:  Clin Cancer Res       Date:  2014-02-03       Impact factor: 12.531

2.  Alveolar soft part sarcoma: Clinicopathological analysis and imaging results.

Authors:  Peng-Fei Qiao; Ling-Hui Shen; Yang Gao; Ying-Chun Mi; Guang-Ming Niu
Journal:  Oncol Lett       Date:  2015-09-10       Impact factor: 2.967

3.  Primary alveolar soft part sarcoma of the lung.

Authors:  Yeong Dae Kim; Chang Hun Lee; Min Ki Lee; Yeon Joo Jeong; Jee Yeon Kim; Do Youn Park; Mee Young Sol
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.